The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

NCT02982798 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Hyperlipidemia

Interventions

DRUG: Metformin + Rosuvastatin
DRUG: JLP-1310

Sponsor

Jeil Pharmaceutical Co., Ltd.